Cutter & Company Brokerage Cut Its Novo Nordisk A S Adr (NVO) Stake by $301,872 as Market Valuation Rose; As Tootsie Roll Inds (TR) Market Value Declined, Shareholder Prospector Partners Has Upped Stake

January 14, 2018 - By Ellis Scott

Cutter & Company Brokerage Inc decreased its stake in Novo Nordisk A S Adr (NVO) by 3.43% based on its latest 2017Q3 regulatory filing with the SEC. Cutter & Company Brokerage Inc sold 6,289 shares as the company’s stock rose 15.20% with the market. The institutional investor held 177,041 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $8.53 million, down from 183,330 at the end of the previous reported quarter. Cutter & Company Brokerage Inc who had been investing in Novo Nordisk A S Adr for a number of months, seems to be less bullish one the $132.50B market cap company. The stock increased 0.15% or $0.08 during the last trading session, reaching $55.04. About 1.10M shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since January 14, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.

Prospector Partners Llc increased its stake in Tootsie Roll Inds Inc (TR) by 20.6% based on its latest 2017Q3 regulatory filing with the SEC. Prospector Partners Llc bought 19,300 shares as the company’s stock declined 6.27% while stock markets rallied. The institutional investor held 113,004 shares of the consumer non-durables company at the end of 2017Q3, valued at $4.29M, up from 93,704 at the end of the previous reported quarter. Prospector Partners Llc who had been investing in Tootsie Roll Inds Inc for a number of months, seems to be bullish on the $2.26B market cap company. The stock decreased 0.28% or $0.1 during the last trading session, reaching $35.7. About 57,038 shares traded. Tootsie Roll Industries, Inc. (NYSE:TR) has risen 4.65% since January 14, 2017 and is uptrending. It has underperformed by 12.05% the S&P500.

Analysts await Novo Nordisk A/S (NYSE:NVO) to report earnings on February, 1. They expect $0.56 EPS, up 12.00% or $0.06 from last year’s $0.5 per share. NVO’s profit will be $1.35 billion for 24.57 P/E if the $0.56 EPS becomes a reality. After $0.62 actual EPS reported by Novo Nordisk A/S for the previous quarter, Wall Street now forecasts -9.68% negative EPS growth.

Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 20 analyst reports since August 28, 2015 according to SRatingsIntel. The stock of Novo Nordisk A/S (NYSE:NVO) earned “Underperform” rating by Bank of America on Friday, October 28. The stock of Novo Nordisk A/S (NYSE:NVO) has “Neutral” rating given on Friday, December 29 by JP Morgan. J.P. Morgan upgraded the stock to “Hold” rating in Friday, December 29 report. The firm earned “Market Perform” rating on Friday, August 28 by Leerink Swann. The stock of Novo Nordisk A/S (NYSE:NVO) earned “Strong Buy” rating by Jyske Bank on Monday, October 19. DNB Markets downgraded the stock to “Hold” rating in Monday, October 31 report. On Wednesday, September 6 the stock rating was upgraded by Bank of America to “Neutral”. The rating was initiated by Piper Jaffray on Friday, September 23 with “Neutral”. The stock has “Hold” rating by HSBC on Wednesday, August 31. The firm has “Buy” rating given on Tuesday, December 6 by UBS.

Prospector Partners Llc, which manages about $2.43B and $659.58 million US Long portfolio, decreased its stake in Brookline Bancorp Inc Del (NASDAQ:BRKL) by 86,300 shares to 202,100 shares, valued at $3.13 million in 2017Q3, according to the filing. It also reduced its holding in Progressive Corp Ohio (NYSE:PGR) by 49,600 shares in the quarter, leaving it with 145,800 shares, and cut its stake in Validus Holdings Ltd (NYSE:VR).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>